Alteration of peripheral blood lymphocyte subsets in essential hypertension

Canadian Journal of Cardiology

Volumn 12, Issue 7, 1996, Pages 657-661

  Sharma, N ^a   Koicha, M ^a   Varma, S ^a   Kumari, S ^a   Ganguly, N K ^a   Sharma, B K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Essential hypertension; Lymphocyte subsets

Indexed keywords

CD22 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR; PHYTOHEMAGGLUTININ;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HUMAN CELL; MALE; MALIGNANT HYPERTENSION; PERIPHERAL LYMPHOCYTE; PROSPECTIVE STUDY; VENOUS BLOOD;

ADULT; ANTIGENS, CD; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION; IMMUNOPHENOTYPING; LYMPHOCYTE SUBSETS; MALE;

EID: 0029770639     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Takeichi N, Boone CW. Spontaneous rosette formation of rat thymus cells with guinea pig erythrocytes. Cell Immunol 1976;27:52-9.
2. Ebringer A, Doyle AE. Raised serum IgG levels in hypertension. BMJ 1970;ii:146-8.
3. Gardner DL, Quagliata F, Drossman M, et al. Attempted prevention of arteriolar lesions in accelerated rat hypertension by immunosuppression. Br J Exp Pathol 1970;51:242-2.
4. Kharaibi AA, Norman RA, Dzielak DJ. Chronic immunosuppression attenuates hypertension in Okamoto spontaneously hypertensive rats. Am J Physiol 1984;247:H722-6.
5. Khraibi AA, Smith TL, Hutchins PM, Lynch CD, Dusseaut JW. Thymectorny delays the development of hypertension in Okamoto spontaneously hypertensive rats. J Hypertens 1987;5:537-41.
6. Bendich A, Belisle EH, Strausser HR. Immune system modulation and its effects on blood pressure of the spontaneously hypertensive male and female rat. Biochem Biophys Res Commun I981;99:600-7.
7. Takeiohi N, Ba D, Kobayashi H. Neutral cytotoxic autoantibody against thymocytes in spontaneously hypertensive rats. Cell Immunol 1981;60:181-90.
8. Ba D, Takeichi N, Kodama T, Kobayashi H. Restoration of T cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts. J Immunol 1982;128:1211-6.
9. Norman RA, Dzielak DJ, Prost KL, Khraili AA, Galloway PG. Immune system dysfunction contributes to aetiology of spontaneous hypertension. J Hypertens 1985;3:261-8.
10. Betaillard A, Freiche JC, Vincent M, Touraine JL, Sassard J. Effects of neonatal thymectomy on blood pressure and immunological characteristics of genetically hypertensive rats of the Lyon strain. J Hypertens 1986;4:5445-7.
11. Holmes MC, Bumel FM. The natural history of auto-immune disease in NZB mice. Ann Intern Med 1963;59:265-76.
12. Svendsen UG. Evidence for initial, thymus independent and a chronic, thymus dependent phase of DOCA and salt hypertension in mice. Acta Pathol Microbiol Scand 1976;84:523-8.
13. Mathews JD, Whittingham S, Mackay IR. Autoimmune mechanisms in human vascular disease. Lancet 1974;ii:1423-7.
14. Svendeen UG. Immunological aspects of hypertension. Int J Immunopharmacol 1979;l:81-4.
15. Kristensen BO. Aspects of immunology and immunogenetics in human essential hypertension with special reference to vascular events. J Hypertens 1984;2:571-9.
16. Kristensen BO. Increased serum levels of immunoglobulins in treated and untreated essential hypertension. Acta Med Scand 1978;203:49-54.
17. Olsen F, Hilden M, Ibsen H. Raised levels of immunglobulins in serum of hypertensive patients. Acta Pathol Microbiol Immunol Scand 1973;81:775-8.
18. Olsen F, Rasmussen S. Delayed hypersensitivity and borderline essential hypertension. Acta Pathol Microbiol Scand 1977;85:196-9.
19. Olsen F, Loft B. Delayed hypersensitivity directed against arterial antigen in hypertensive disease in man. Acta Path Microbiol Scand Sect B. 1973;81:498-503.
20. Olsen F. Hypersensitivity of delayed type in hypertensive patients. Acta Pathol Microbiol Immunol Scand 1991;99:65-8.
21. Hilme E, Herlitz H, Soderstrom T, Hansson T. Increased secretion of immunoglobulins in malignant hypertension. J Hypertens 1989;7:91-5.
22. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The 1988 report. Arch Intern Med 1988;148:1023-38.
23. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APPAP complexes). J Histochem Cytochem 1984;32:219-29.
24. Erber WN, Pinching AL, Mason DY. Immunochemical detection of T and B cell population on routine blood smears. Lancet 1984;i:1042-5.
25. Matsui Y. Increased density of class I major histocornpatability complex antigens and decreased density of T cell differentiation antigen in early stages of T cell activation. Hum Immunol 1987;18:123-33.
26. Weyand CM, Goranzy J, Fathman CJ. Modulation of CD4 by antigenic activation. J Immunol 1987;138:1351-4.
27. Ivan MR, Delvis PJ, eds. Encyclopedia of Immunology, Vol. 1. London: Academic Press, 1992;307-11.
28. Stamenkovic I, Seed B. The B cell antigen CD22 mediates monocyte and erythrocyte adhesion. Nature 1990;345:74-7.
29. Noelle JJ, Snow EC. Cognate interactions between Helper T cells and B cells. Immunol Today 1990;11:361-8.
30. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-33.
31. Kristensen BO, Anderson PL. Autoantibodies in treated and untreated essential hypertension. Acta Med Scand 1978;203:55-9.
32. Sharma S, Talwar KK, Ganguly NK, Rissam HS, Sharma BK. Cell mediated immunity in hypertension-preliminary observations. Bull Postgrad Inst Med Edu Res 1983;17:159-62.